Raptor Pharmaceuticals Corp. (Raptor) is a biopharmaceutical company that develops and commercializes therapeutics for orphan diseases. The company's lead product, Procysbi is a cysteamine bitartrate delayed-release capsule and is used in the treatment of a rare genetic disorder, nephropathic cystinosis. Its second product, Quinsair finds application in treating chronic pulmonary infections due to Pseudomonas aeruginosa in adults with cystic fibrosis. Raptor's clinical stage product candidates include RP103, non-alcoholic fatty liver disease, and Convivia. The company offers preclinical programs such as HepTide, for the treatment of primary liver cancer; and ADO (cysteamine dioxygenase), for the treatment of diseases for which cysteamine is a medicine. Raptor is headquartered in Novato, California, the US.
Raptor Pharmaceutical Corp. Key Recent Developments
Aug 04, 2016: Raptor Pharmaceutical Reports Second Quarter 2016 Financial Results
May 05, 2016: Raptor Pharmaceutical Reports First Quarter 2016 Financial Results
Feb 25, 2016: Raptor Pharmaceutical Reports Fourth Quarter and Full Year 2015 Financial Results and Provides 2016 Corporate Update
Nov 05, 2015: Raptor Pharmaceutical Reports Third Quarter 2015 Financial Results and Provides Corporate Update
Aug 06, 2015: Raptor Pharmaceutical Reports Second Quarter 2015 Financial Results and Provides Corporate Update
This comprehensive SWOT profile of Raptor Pharmaceutical Corp. provides you an in-depth strategic analysis of the company's businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company's key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
This company report forms part of GlobalData's 'Profile on Demand' service, covering over 50,000 of the world's leading companies. Once purchased, GlobalData's highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of Raptor Pharmaceutical Corp. including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).
The profile contains critical company information including*,
Business description-A detailed description of the company's operations and business divisions.
Corporate strategy-Analyst's summarization of the company's business strategy.
SWOT Analysis-A detailed analysis of the company's strengths, weakness, opportunities and threats.
Company history-Progression of key events associated with the company.
Major products and services-A list of major products, services and brands of the company.
Key competitors-A list of key competitors to the company.
Key employees-A list of the key executives of the company.
Executive biographies-A brief summary of the executives' employment history.
Key operational heads-A list of personnel heading key departments/functions.
Important locations and subsidiaries-A list and contact details of key locations and subsidiaries of the company.
Key manufacturing facilities-A list of key manufacturing facilities of the company.
Detailed financial ratios for the past five years-The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
Interim ratios for the last five interim periods-The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Note*: Some sections may be missing if data is unavailable for the company.
Key benefits of buying this profile include,
You get detailed information about the company and its operations to identify potential customers and suppliers.
The profile analyzes the company's business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors' business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
The company's core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies' strategic, financial and operational performance.
Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Table of Contents
Section 1-About the Company
Raptor Pharmaceutical Corp.-Key Information
Raptor Pharmaceutical Corp.-Overview
Raptor Pharmaceutical Corp.-Key Employees
Raptor Pharmaceutical Corp.-Key Employee Biographies
Raptor Pharmaceutical Corp.-Key Operational Heads
Raptor Pharmaceutical Corp.-Major Products and Services
Raptor Pharmaceutical Corp.-History
Raptor Pharmaceutical Corp.-Company Statement
Raptor Pharmaceutical Corp.-Locations And Subsidiaries
Raptor Pharmaceutical Corp.-Key Manufacturing facilities
Other Locations & Subsidiaries
Section 2-Company Analysis
Raptor Pharmaceutical Corp.-Business Description
Raptor Pharmaceutical Corp.-Corporate Strategy
Raptor Pharmaceutical Corp.-SWOT Analysis
Raptor Pharmaceutical Corp.-Strengths
Raptor Pharmaceutical Corp.-Weaknesses
Raptor Pharmaceutical Corp.-Opportunities
Raptor Pharmaceutical Corp.-Threats
Raptor Pharmaceutical Corp.-Key Competitors
Section 3-Company Financial Performance Charts
Raptor Pharmaceutical Corp.-Financial Ratios
Financial Ratios-Capital Market Ratios
Financial Ratios-Annual Ratios
Financial Ratios-Interim Ratios
Financial Ratios-Ratio Charts
Note*: Some sections may be missing if data is unavailable for the company
List of Figures
Raptor Pharmaceutical Corp., Performance Chart
Raptor Pharmaceutical Corp., Ratio Charts
List of Tables
Raptor Pharmaceutical Corp., Key Information
Raptor Pharmaceutical Corp., Key Ratios
Raptor Pharmaceutical Corp., Share Data
Raptor Pharmaceutical Corp., Major Products and Services
Raptor Pharmaceutical Corp., History
Raptor Pharmaceutical Corp., Key Employees
Raptor Pharmaceutical Corp., Key Employee Biographies
Raptor Pharmaceutical Corp., Key Operational Heads
Raptor Pharmaceutical Corp., Other Locations
Raptor Pharmaceutical Corp., Subsidiaries
Raptor Pharmaceutical Corp., Key Manufacturing facilities
Raptor Pharmaceutical Corp., Key Competitors
Raptor Pharmaceutical Corp., SWOT Analysis
Raptor Pharmaceutical Corp., Ratios based on current share price
Raptor Pharmaceutical Corp., Annual Ratios
Raptor Pharmaceutical Corp., Interim Ratios
Capital Market Ratios
Single User License:
Corporate User License:
Raptor Pharmaceutical Corp., SWOT analysis, SWOT, Strengths, Weaknesses, Opportunities, Threats, Corporate Strategy, Key Ratios, Share Data, Performance, Financial Performance, Overview, Business Description, Major Product, Brands, History, Key Employees, Key Operational Heads, Strategy, Key Competitors, Company Statement, Capital Market Ratios, Financial Ratios, Annual Ratios, Interim Ratios, Ratio Charts
select a license
NEWSLETTER BY CATEGORY
The report sent to us was on the point, and its information was quite extensive, well structured, and well researched. More importantly what we valued was your response time and professionalism. As a leading global consulting firm, our clients expect high quality deliverables in short periods of time, so a reliable research partner is essential. For the price that you have charged the quality of your services were exceptional. We look forward to continue our relationship with your team on future engagements.... "Senior Associate, Booz Allen Hamilton"
This is with regards to your report on India PVC pipes and fitting market outlook industry outlook to 2019. This is a very well written report and accept my compliments on the same.... ... "Mohit Mittal, Consultant, KPMG Advisory Services"
I am pleased to see the very useful and productive information in the report..Very well structured great presentation reflect professionalism in your research studies.... "Mustafa Masood, Financial Analyst , Coldwell Banker Riyadh"
While we still are studying and analysing your reports about Vietnam & Thailand, we would like to convey to your research team that they have done a very good job in compiling so much of information together. We hope to see more of such well researched reports. All the best & keep it up. ... "Prashant Bhagwat,General Manager, Mahindra"
We would like to appreciate Ken Research for their great efforts and wonderful support in providing the Market Intelligence Report for ITPC. The information, statistics and research are well understandable and very clear to the point. We are happy with Ken research for their good client service, on-time delivery of the report and as said the report itself. Thank you Ken research for bringing the valuable output for us. We would be looking forward to have more research with you in the near future. Wish you a success in your business!... "Jestin Mathew, Indonesian Trade Promotion Center"